세계 침술용 침 시장 : 규모, 점유율, 동향 분석 보고서 - 제품별, 재료별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Acupuncture Needles Market Size, Share & Trends Analysis Report By Product (Disposable Needles, Non-disposable Needles), By Material (Stainless Steel, Silver, Others), By End-use, By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,545,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,981,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,853,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

침술용 침의 성장과 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 세계 침술용 침 규모는 2030년까지 5억 3,411만 달러에 이르렀으며 복합 연간 성장률(CAGR) 8.81%로 확대될 것으로 예측됩니다.

앉아있는 라이프 스타일 채용 증가, 노인 인구 증가, 감정 장애의 발생률의 상승이 시장을 견인하는 주요 요인입니다.

침술용 침는 중국의 전통적인 의료 행위에서 파생된 전통적인 치료법입니다. 치료에는 신체의 특정 항아리에 얇은 침술용 침을 찌르는 것이 포함됩니다. 이 기술은 관절 질환, 두통, 수술 및 만성 질환으로 인한 신체 통증, 편두통, 월경통, 마비와 같은 여러 증상으로 인한 통증을 완화하는 데 도움이 됩니다. 또한 감정 장애, 메스꺼움, 언어 장애, 소화기 질환, 호흡기 질환, 불면증 등 특정 주요 문제를 치료하는 것으로 알려져 있습니다. 침술용 침는 또한 흡연과 음주와 같은 특정 유해한 중독을 제거하는 데 도움이 됩니다.

감정 장애와 만성 질환의 증례가 증가하는 것이 시장 성장을 뒷받침하는 주요 요인입니다. 미국 전국 행동 위생 협의회(National Council for Behavioral Health)가 2019년에 발표한 보고서에 따르면 미국에서는 인구의 거의 절반이 평생 동안 어떤 정신 질환으로 고통받고 있다고 합니다. 또한 미국에서는 성인의 약 5.0%가 1년간 정신장애를 경험한다고 보고되었으며, 이는 미국에서는 거의 4,380만 명에 해당합니다. 국립생물공학정보센터(NCBI)에 따르면 침술용 침치료와 에너지심리학은 심각한 부작용을 일으키지 않고 감정장애의 치료와 진단에 모두 효율적으로 작용합니다. 따라서, 이 기술의 이러한 장점과 유용성은 세계 많은 사람들이 이러한 정서적 상태의 치료를 위해이 기술을 선택하도록 권장합니다. 따라서 예측 기간 동안 상당한 시장 성장이 예상됩니다.

침술용 침 보고서 하이라이트

• 수익 측면에서 일회용 침술용 침 부문은 2023년에 가장 큰 점유율을 차지했습니다. 사람에서 사람으로의 질병 감염 위험이 낮다는 것은 예측 기간 동안이 부문을 견인하는 주요 요인입니다.
• 스테인레스 스틸 부문은 원재료의 입수가 용이하고 저비용이기 때문에 2023년 최대 시장 점유율을 차지했습니다.
• 병원 부문은 만성 질환으로 인한 합병증 증가로 예측 기간 동안 가장 빠른 성장률을 나타낼 것으로 예측됩니다.
• 아시아태평양은 수술 건수가 증가하고 있으며 현지의 주요 기업이 다수 존재하기 때문에 예측 기간 중에 가장 빠른 성장이 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 침술용 침 시장 : 변수, 동향, 범위

• 시장 계통 전망
  • 상위 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 침술용 침 시장 분석 도구
  • 업계 분석 - Porter's Five Forces 분석
  • PESTEL 분석
  • 가격 분석

제4장 침술용 침 시장 : 제품의 추정,동향 분석

• 제품 시장 점유율(2023년,2030년)
• 부문 대시보드
• 제품별 세계 침술용 침 시장 전망
• 시장 규모, 예측 및 동향 분석(2018년-2030년)

제5장 침술용 침 시장 : 재료의 추정,동향 분석

• 재료 시장 점유율(2023년,2030년)
• 부문 대시보드
• 재료별 세계 침술용 침 시장 전망
• 시장 규모, 예측 및 동향 분석(2018년-2030년)

제6장 침술용 침 시장 : 최종 용도의 추정,동향 분석

• 최종 용도 시장 점유율(2023년,2030년)
• 부문 대시보드
• 최종 용도별 세계 침술용 침 시장 전망
• 시장 규모, 예측 및 동향 분석(2018년-2030년)

제7장 침술용 침 시장 : 지역의 추정,동향 분석

• 지역 시장 점유율 분석(2023년,2030년)
• 지역 시장 대시보드
• 세계 지역 시장 현황
• 시장 규모와 예측 동향 분석(2018년-2030년)
• 북미
  • 미국
  • 캐나다
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제8장 경쟁 구도

• 주요 시장 진출기업별 최근의 동향과 영향 분석
• 회사/경쟁의 분류
• 벤더 상황
  • 3B SCIENTIFIC GMBH
  • AcuMedic Ltd.
  • asia-med GmbH
  • SEIRIN
  • Dana Medical Co.
  • Boen Healthcare Co., Ltd.
  • Suzhou Hualun Medical Appliance Co., Ltd.
  • WUXI JIAJIAN MEDICAL DEVICES CO., LTD.
  • Suzhou Zhongjing Life &Science Technology Co., Ltd.
  • Shinylink(상하이) Industrial Inc.

BJH

영문 목차

영문목차

Acupuncture Needles Market Growth & Trends:

The global acupuncture needles market size is expected to reach USD 534.11 million by 2030, expanding at a CAGR of 8.81%, according to a new report by Grand View Research, Inc. The increase in the adoption of sedentary lifestyles, growing geriatric population, and rising incidence of emotional disorders are the key factors driving the market.

Acupuncture is a traditional healing practice derived from traditional medical practice in China. The treatment involves placing thin needles at specific pressure points of the body. This technique helps in reducing the pain caused due to several conditions such as joint conditions, headache, body pain due to surgeries and chronic disorders, migraines, menstrual cramps, and paralysis. It is also known for treating certain major issues such as emotional disorders, nausea, speech disorders, digestive disorders, respiratory conditions, and insomnia. Acupuncture also helps to get rid of certain harmful addictions such as smoking and alcohol consumption.

The rising cases of emotional disorders and chronic conditions are the major factors boosting the market growth. According to the report published by the National Council for Behavioral Health in 2019, in the U.S. almost half of the population suffers from some kind of mental illness throughout their lifetime. It also reported that around 5.0% of the adults in the country experience mental disorder in any one year, which is almost 43.8 million people in the U.S. As per the National Center for Biotechnology Information (NCBI), acupuncture and energy psychology together work efficiently in the treatment and diagnosis of emotional disorders without causing any severe side-effects. Therefore, such advantages and usefulness of this technique have encouraged many people across the globe, to opt for this technique for the treatment of such emotional conditions. Thus, considerable market growth is anticipated over the forecast period.

Acupuncture Needles Market Report Highlights:

• In terms of revenue, the disposable needles segment held the largest share in 2023. The low risk of transmission of any disease from one person to another is the major factor driving the segment over the forecast period
• The stainless steel segment held the largest market share in 2023 owing to the easy availability of raw materials and low cost
• The hospital segment is anticipated to witness the fastest growth rate over the forecast period owing to the rising complications caused due to chronic disorders
• Asia Pacific is anticipated to witness the fastest growth over the forecast period owing to the rising number of surgeries and the presence of many local key players

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Material
  • 1.2.3. End-use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product
  • 2.2.2. Material
  • 2.2.3. End-use
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Acupuncture Needles Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increase in adoption of acupuncture for pain management
    • 3.2.1.2. Rise in gynecological disorders
    • 3.2.1.3. Surge in health complications in the geriatric population
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Risk of infections caused due to the use of reusable needles
• 3.3. Acupuncture Needles Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Pricing Analysis

Chapter 4. Acupuncture Needles Market: Product Estimates & Trend Analysis

• 4.1. Product Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Acupuncture Needles Market by Product Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Disposable Needles
    • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Non-disposable Needles
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Acupuncture Needles Market: Material Estimates & Trend Analysis

• 5.1. Material Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Acupuncture Needles Market by Material Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Stainless Steel
    • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Silver
    • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Others
    • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Acupuncture Needles Market: End-use Estimates & Trend Analysis

• 6.1. End-use Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Acupuncture Needles Market by End-use Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4.1. Clinics
    • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 6.4.2. Hospital
    • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Others
    • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Acupuncture Needles Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework/ reimbursement structure
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework/ reimbursement structure
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Norway
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework/ reimbursement structure
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Regulatory framework/ reimbursement structure
    • 7.6.7.3. Competitive scenario
    • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.8. Denmark
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Regulatory framework/ reimbursement structure
    • 7.6.8.3. Competitive scenario
    • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework/ reimbursement structure
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Regulatory framework/ reimbursement structure
    • 7.7.6.3. Competitive scenario
    • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework/ reimbursement structure
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.2. Mexico
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework/ reimbursement structure
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.3. Argentina
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Regulatory framework/ reimbursement structure
    • 7.8.3.3. Competitive scenario
    • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Regulatory framework/ reimbursement structure
    • 7.9.1.3. Competitive scenario
    • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Regulatory framework/ reimbursement structure
    • 7.9.2.3. Competitive scenario
    • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Regulatory framework/ reimbursement structure
    • 7.9.3.3. Competitive scenario
    • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Regulatory framework/ reimbursement structure
    • 7.9.4.3. Competitive scenario
    • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2023
  • 8.3.4. 3B SCIENTIFIC GMBH
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. AcuMedic Ltd.
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. asia-med GmbH
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. SEIRIN
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Dana Medical Co.
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Boen Healthcare Co., Ltd.
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Suzhou Hualun Medical Appliance Co., Ltd.
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. WUXI JIAJIAN MEDICAL DEVICES CO., LTD.
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Suzhou Zhongjing Life & Science Technology Co., Ltd.
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. Shinylink (Shanghai) Industrial Inc.
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives

관련자료